loading
전일 마감가:
$2.17
열려 있는:
$2.25
하루 거래량:
434.69K
Relative Volume:
0.30
시가총액:
$26.13M
수익:
-
순이익/손실:
$-45.57M
주가수익비율:
-0.3984
EPS:
-6.3
순현금흐름:
$-38.56M
1주 성능:
+9.61%
1개월 성능:
-2.71%
6개월 성능:
+74.91%
1년 성능:
-9.06%
1일 변동 폭
Value
$2.10
$2.54
1주일 범위
Value
$2.10
$2.54
52주 변동 폭
Value
$1.00
$6.60

Sab Biotherapeutics Inc Stock (SABS) Company Profile

Name
명칭
Sab Biotherapeutics Inc
Name
전화
305-845-2813
Name
주소
777 W 41ST ST, MIAMI BEACH
Name
직원
63
Name
트위터
Name
다음 수익 날짜
2024-11-12
Name
최신 SEC 제출 서류
Name
SABS's Discussions on Twitter

SABS을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
SABS
Sab Biotherapeutics Inc
2.51 22.59M 0 -45.57M -38.56M -6.30
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
416.81 104.76B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
481.67 63.06B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
578.05 60.32B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
843.66 51.55B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
165.76 34.49B 398.11M -1.03B -868.57M -5.7032

Sab Biotherapeutics Inc Stock (SABS) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-09-17 개시 Leerink Partners Outperform
2025-05-14 재개 H.C. Wainwright Buy
2024-10-09 개시 Craig Hallum Buy
2024-08-28 개시 Oppenheimer Outperform
2021-11-05 개시 Chardan Capital Markets Buy

Sab Biotherapeutics Inc 주식(SABS)의 최신 뉴스

pulisher
04:03 AM

Can SAB Biotherapeutics Inc. Equity Warrant stock resist sector downturns2025 Market Overview & Real-Time Volume Analysis Alerts - newser.com

04:03 AM
pulisher
Oct 17, 2025

What technical models suggest about SAB Biotherapeutics Inc. Equity Warrant’s comebackMarket Risk Report & Consistent Income Trade Recommendations - newser.com

Oct 17, 2025
pulisher
Oct 17, 2025

Why SAB Biotherapeutics Inc. Equity Warrant stock is rated strong buyJuly 2025 Fed Impact & Weekly High Conviction Trade Ideas - Trung tâm Dự báo KTTV quốc gia

Oct 17, 2025
pulisher
Oct 17, 2025

Tick level data insight on SAB Biotherapeutics Inc. volatilityWeekly Trade Recap & Intraday High Probability Alerts - newser.com

Oct 17, 2025
pulisher
Oct 17, 2025

Analyst Upgrade: Is SAB Biotherapeutics Inc. stock ready for breakoutJuly 2025 Rallies & Stepwise Entry and Exit Trade Signals - Trung tâm Dự báo KTTV quốc gia

Oct 17, 2025
pulisher
Oct 17, 2025

Will SAB Biotherapeutics Inc. stock deliver consistent dividendsJuly 2025 Sentiment & Fast Momentum Entry Tips - newser.com

Oct 17, 2025
pulisher
Oct 17, 2025

Will SAB Biotherapeutics Inc. Equity Warrant stock benefit from sector rotationWeekly Market Outlook & Safe Entry Trade Signal Reports - newser.com

Oct 17, 2025
pulisher
Oct 15, 2025

How sustainable is SAB Biotherapeutics Inc. Equity Warrant stock dividend payoutPortfolio Update Report & Free Daily Entry Point Trade Alerts - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

How SAB Biotherapeutics Inc. Equity Warrant stock performs in interest rate cyclesJuly 2025 Patterns & Safe Entry Momentum Tips - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Will breakout in SAB Biotherapeutics Inc. lead to full recoveryMarket Rally & Fast Exit Strategy with Risk Control - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

SAB Biotherapeutics (NASDAQ:SABS) Receives “Sell (E+)” Rating from Weiss Ratings - Defense World

Oct 15, 2025
pulisher
Oct 15, 2025

Will SAB Biotherapeutics Inc. Equity Warrant stock benefit from upcoming earnings reportsInflation Watch & Consistent Return Investment Signals - newser.com

Oct 15, 2025
pulisher
Oct 14, 2025

Can SAB Biotherapeutics Inc. stock sustain institutional interestMarket Sentiment Summary & Consistent Growth Equity Picks - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

How to build a custom watchlist for SAB Biotherapeutics Inc. Equity WarrantPortfolio Risk Summary & Short-Term Swing Trade Alerts - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

Will SAB Biotherapeutics Inc. stock see PE expansion2025 Market WrapUp & Precise Buy Zone Identification - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

Why retail investors pile into SAB Biotherapeutics Inc. stockEarnings Growth Summary & Growth-Oriented Investment Plans - newser.com

Oct 14, 2025
pulisher
Oct 13, 2025

SAB Biotherapeutics Inc Equity Warrant Stock Analysis and ForecastStochastic Oscillator Alerts & Low Entry Cost Investments - earlytimes.in

Oct 13, 2025
pulisher
Oct 13, 2025

How to monitor SAB Biotherapeutics Inc. with trend dashboards2025 Trading Volume Trends & Entry Point Confirmation Signals - newser.com

Oct 13, 2025
pulisher
Oct 12, 2025

Is SAB Biotherapeutics Inc. stock bottoming outJuly 2025 Snapshot & Free High Accuracy Swing Entry Alerts - newser.com

Oct 12, 2025
pulisher
Oct 12, 2025

SAB Biotherapeutics Inc. Equity Warrant stock outlook for YEARWeekly Trade Report & AI Powered Buy/Sell Recommendations - newser.com

Oct 12, 2025
pulisher
Oct 10, 2025

Is SAB Biotherapeutics Inc a good long term investmentInsider Trading Activity & Big Profit Low Investment - earlytimes.in

Oct 10, 2025
pulisher
Oct 10, 2025

Should you wait for a breakout in SAB Biotherapeutics Inc.Quarterly Earnings Report & Risk Controlled Daily Plans - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Using Ichimoku Cloud for SAB Biotherapeutics Inc. Equity Warrant technicalsWeekly Trade Recap & Precise Buy Zone Identification - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

How to track smart money flows in SAB Biotherapeutics Inc. Equity WarrantJuly 2025 EndofMonth & Weekly Top Gainers Alerts - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

SABSW Stock Institutional Owners - Quiver Quantitative

Oct 10, 2025
pulisher
Oct 10, 2025

Is SAB Biotherapeutics Inc. stock reversal real or fake2025 Market Outlook & Risk Managed Investment Strategies - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

COMMODORE CAPITAL LP Acquires Significant Stake in SAB Biotherap - GuruFocus

Oct 09, 2025
pulisher
Oct 09, 2025

RA CAPITAL MANAGEMENT, L.P. Acquires Significant Stake in SAB Bi - GuruFocus

Oct 09, 2025
pulisher
Oct 09, 2025

Will SAB Biotherapeutics Inc. Equity Warrant stock recover after recent dropWeekly Trade Summary & Verified Short-Term Trading Plans - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Will SAB Biotherapeutics Inc. Equity Warrant bounce back from current supportJuly 2025 Review & Daily Technical Forecast Reports - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

How to interpret RSI for SAB Biotherapeutics Inc. stockTrade Volume Report & Real-Time Sentiment Analysis - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Advanced analytics toolkit walkthrough for SAB Biotherapeutics Inc.Market Growth Summary & Real-Time Chart Breakout Alerts - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Is SAB Biotherapeutics Inc. stock entering bullish territoryWeekly Risk Report & Weekly Top Gainers Trade List - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Published on: 2025-10-09 02:46:01 - newser.com

Oct 09, 2025
pulisher
Oct 07, 2025

What drives SAB Biotherapeutics Inc stock priceIPO Market Watch & High Return Trading Ideas - earlytimes.in

Oct 07, 2025
pulisher
Oct 06, 2025

Can technical indicators confirm SAB Biotherapeutics Inc.’s reversalEarnings Recap Summary & Risk Managed Investment Entry Signals - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Institutional scanner results for SAB Biotherapeutics Inc. Equity Warrant2025 Historical Comparison & Reliable Intraday Trade Plans - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Strategies to average down on SAB Biotherapeutics Inc. Equity WarrantWeekly Loss Report & Community Verified Swing Trade Signals - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Will SAB Biotherapeutics Inc. see short term momentumDollar Strength & Fast Entry High Yield Stock Tips - newser.com

Oct 05, 2025

Sab Biotherapeutics Inc (SABS) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Sab Biotherapeutics Inc 주식 (SABS) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Sessa Capital (Master), L.P.
Director
Sep 29 '25
Option Exercise
1.75
1,740,000
3,045,000
2,198,457
$37.01
price up icon 1.84%
$87.57
price up icon 0.30%
$33.17
price up icon 1.28%
$105.14
price up icon 0.06%
biotechnology ONC
$316.42
price down icon 0.50%
$165.76
price up icon 1.57%
자본화:     |  볼륨(24시간):